RC
CVS icon

Roundview Capital’s CVS Health CVS Stock Holding History

Roundview Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Buy
13,733
+445
+3% +$39.7K 0.08% 201
2026
Q1 		$954K Buy
+13,288
New +$1.02M 0.06% 216
2023
Q2 		– Sell
-2,929
Closed -$218K – 313
2023
Q1 		$218K Sell
2,929
-429
-13% -$36K 0.02% 304
2022
Q4 		$313K Sell
3,358
-184
-5% -$17.8K 0.04% 255
2022
Q3 		$338K Sell
3,542
-17,119
-83% -$1.69M 0.04% 239
2022
Q2 		$1.91M Buy
20,661
+19
+0.1% +$1.85K 0.23% 116
2022
Q1 		$2.09M Sell
20,642
-7,869
-28% -$827K 0.21% 116
2021
Q4 		$2.94M Sell
28,511
-745
-3% -$68.8K 0.29% 89
2021
Q3 		$2.48M Buy
29,256
+951
+3% +$79.7K 0.27% 95
2021
Q2 		$2.36M Buy
28,305
+4,765
+20% +$390K 0.26% 97
2021
Q1 		$1.77M Buy
23,540
+5,860
+33% +$427K 0.22% 117
2020
Q4 		$1.21M Sell
17,680
-115
-0.6% -$7.48K 0.17% 137
2020
Q3 		$1.04M Buy
17,795
+125
+0.7% +$7.78K 0.16% 132
2020
Q2 		$1.15M Buy
17,670
+621
+4% +$39.1K 0.2% 122
2020
Q1 		$1.01M Sell
17,049
-8,613
-34% -$575K 0.21% 118
2019
Q4 		$1.91M Buy
25,662
+903
+4% +$63.4K 0.36% 86
2019
Q3 		$1.56M Buy
24,759
+16,090
+186% +$953K 0.34% 87
2019
Q2 		$472K Sell
8,669
-5,763
-40% -$310K 0.11% 175
2019
Q1 		$778K Sell
14,432
-650
-4% -$40.1K 0.18% 133
2018
Q4 		$988K Buy
15,082
+1,538
+11% +$115K 0.28% 99
2018
Q3 		$1.07M Sell
13,544
-700
-5% -$50K 0.26% 106
2018
Q2 		$917K Buy
14,244
+10,865
+322% +$716K 0.24% 114
2018
Q1 		$210K Sell
3,379
-3,436
-50% -$247K 0.06% 202
2017
Q4 		$494K Sell
6,815
-290
-4% -$21.1K 0.13% 161
2017
Q3 		$578K Sell
7,105
-1,355
-16% -$107K 0.17% 146
2017
Q2 		$681K Buy
8,460
+804
+11% +$63.5K 0.2% 128
2017
Q1 		$601K Buy
7,656
+240
+3% +$19.2K 0.19% 138
2016
Q4 		$585K Buy
+7,416
New +$600K 0.19% 136

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Roundview Capital's CVS Position: Q2 2026 in Review

Roundview Capital increased its CVS Health (CVS) stake by 3.3% in Q2 2026, buying an estimated $39.7K and bringing the position to 13,733 shares worth $1.42M. The position accounts for 0.08% of the portfolio, ranked #201.

Roundview Capital first reported a position in CVS in Q4 2016 and has held it in 28 quarters since. The position peaked at $2.94M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Roundview Capital held 13,733 shares of CVS Health worth $1.42M as of Q2 2026.
  • Roundview Capital bought 445 CVS Health shares in Q2 2026, an estimated $39.7K.
  • CVS Health made up 0.08% of Roundview Capital's portfolio in Q2 2026, its #201 holding.
  • Roundview Capital first reported a position in CVS Health in Q4 2016 and has held it in 28 quarters since.
  • Roundview Capital's CVS Health position peaked at $2.94M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Roundview Capital's 13F filing for Q2 2026, filed 30 Jul 2026.